Form 4 GERON CORP For: Jun 06 Filed by: Samuels Scott Alan

Go back to Form 4 GERON CORP For: Jun 06 Filed by: Samuels Scott Alan

Geron Corporation (GERN) PT Raised to $6 at Goldman Sachs

June 10, 2024 11:59 AM EDT

Goldman Sachs analyst Corinne Jenkins raised the price target on Geron Corporation (NASDAQ: GERN) to $6.00 (from $5.00) while maintaining a Buy rating.

The analyst comments "GERN is trading +19.7% (vs. -1.6% for the XBI) intraday following the FDA approval of Rytelo (imetelstat) in lower-risk myelodysplastic syndrome (LR-MDS).... More